Rising Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RISING
RISING has three hundred and thirty-two approved drugs.
There are three tentative approvals on RISING drugs.
Summary for Rising
| US Patents: | 0 |
| Tradenames: | 257 |
| Ingredients: | 250 |
| NDAs: | 332 |
Drugs and US Patents for Rising
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rising | BENAZEPRIL HYDROCHLORIDE | benazepril hydrochloride | TABLET;ORAL | 076430-004 | Feb 11, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Rising | SULFAMYLON | mafenide acetate | CREAM;TOPICAL | 016763-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Rising | INDOMETHACIN | indomethacin | CAPSULE;ORAL | 070624-001 | Sep 4, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Rising | NORTRIPTYLINE HYDROCHLORIDE | nortriptyline hydrochloride | CAPSULE;ORAL | 074234-003 | Jul 26, 1993 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Rising | NOREPINEPHRINE BITARTRATE | norepinephrine bitartrate | INJECTABLE;INJECTION | 218758-001 | May 13, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rising | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 202228-004 | Feb 2, 2021 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Rising
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Rising | EXTINA | ketoconazole | AEROSOL, FOAM;TOPICAL | 021738-001 | Jun 12, 2007 | 7,553,835 | ⤷ Start Trial |
| Rising | ALFENTA | alfentanil hydrochloride | INJECTABLE;INJECTION | 019353-001 | Dec 29, 1986 | 4,167,574 | ⤷ Start Trial |
| Rising | SULFAMYLON | mafenide acetate | CREAM;TOPICAL | 016763-001 | Approved Prior to Jan 1, 1982 | 3,497,599 | ⤷ Start Trial |
| Rising | SUFENTA PRESERVATIVE FREE | sufentanil citrate | INJECTABLE;INJECTION | 019050-001 | May 4, 1984 | 3,998,834 | ⤷ Start Trial |
| Rising | EXTINA | ketoconazole | AEROSOL, FOAM;TOPICAL | 021738-001 | Jun 12, 2007 | 8,026,238 | ⤷ Start Trial |
| Rising | OPTIVAR | azelastine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021127-001 | May 22, 2000 | 5,164,194 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for RISING drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Ophthalmic Solution | 0.05% | ➤ Subscribe | 2006-12-13 |
| ➤ Subscribe | Foam | 2% | ➤ Subscribe | 2009-07-30 |
| ➤ Subscribe | Nasal Spray | 0.125 mg base/spray | ➤ Subscribe | 2005-11-14 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
